CORONA DRUG SURVEY

CORONA DRUG SURVEY

Have you used psychoactive substances – including alcohol, nicotine, cannabis, heroin, cocaine, psychedelics or others – in the last two years (2019 and 2020)?

Then take part in our online survey!

The Corona Drug Survey is conducted by the Psychotropic Substances Group of Charité – Universitätsmedizin Berlin. The aim of the study is to determine how the consumption of psychoactive substances has changed as a result of the COVID-19 pandemic (“corona crisis”). In the Corona Drug Survey (CDS), we investigate how the current situation affects the subjective experience and use of psychoactive substances. We also want to find out whether there are differences between substances.

PARTICIPATION IS ANONYMOUS

Participation in the survey is completely anonymous and no IP address is stored. It is therefore not possible for us to track who filled out the questionnaire.

This survey is carried out by:

Tomislav Majić

Dr. Tomislav Majić

is a psychiatrist, psychotherapist and head of the Psychotropic Substances Research Group at the Psychiatric University Hospital Charité at St. Hedwig Hospital in Berlin. He is head of the Outpatient Clinic and Day Clinic for Dual Diagnosis and the Outpatient Clinic for Psychoactive Substances, where people who have experienced mental disorders or problems integrating difficult experiences after taking psychedelics or other substances are treated.

PD Dr. Inge Maria Mick

is a psychiatrist and psychotherapist at the Psychiatric University Hospital Charité at St. Hedwig Hospital in Berlin. She is head of the outpatient department for addictive disorders and leads a general psychiatric ward.

Christiane Montag

PD Dr. Christiane Montag

is a specialist in psychiatry and psychotherapy / psychoanalysis at the Psychiatric University Hospital Charité at St. Hedwig Hospital in Berlin. She is head of the research area Psychotic Diseases and is particularly interested in the effectiveness of psychotherapy, but also in empathy and emotionality in people with psychoses. Her clinical field of activity is general psychiatry and a model project for need-based treatment.

Dr. Ricarda Evens

is a psychologist, psychotherapist and member of the Psychotropic Substances Research Group at the Department of Psychiatry and Psychotherapy at the Psychiatric University Hospital Charité at St. Hedwig Hospital. Her research focuses on potential benefits of substance-assisted psychotherapy.

In cooperation with Felix Betzler, M.D.
Research Group Recreational Drugs
Charité Campus Mitte

CONTACT

Dr. Tomislav Majić
Head of Psychotropic Substances Research Group, St. Hedwig-Krankenhaus
Charité – Universitätsmedizin Berlin

corona-drugsurvey@charite.de